BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8953587)

  • 21. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute lymphoblastic leukemia in children.
    Cagen D; Franco M
    Clin J Oncol Nurs; 2003; 7(5):604-6. PubMed ID: 14603563
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cell surface markers and treatment results in childhood acute lymphoblastic leukemia (ALL)].
    Koizumi S; Tsurusawa M; Katano N
    Rinsho Ketsueki; 1997 May; 38(5):389-92. PubMed ID: 9194381
    [No Abstract]   [Full Text] [Related]  

  • 25. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
    Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
    Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute lymphoblastic leukemia with Philadelphia chromosome: eight case reports].
    Laatiri MA; Chehata S; Amouri A; Sendi HS; Saad A; Ennabli S
    Tunis Med; 2001 Jan; 79(1):38-41. PubMed ID: 11332342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent advance in treatment of childhood acute lymphoblastic leukemia].
    Watanabe A
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):150-5. PubMed ID: 17301519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognosis and diagnosis of a case of acute leukemia].
    Donadieu J
    Soins Pediatr Pueric; 1999; (189):7-8. PubMed ID: 10808945
    [No Abstract]   [Full Text] [Related]  

  • 29. Dying to predict outcome.
    Hogan LE; Raetz EA
    Pediatr Blood Cancer; 2010 Jul; 55(1):5-6. PubMed ID: 20486162
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study.
    Horibe K; Hara J; Yagi K; Tawa A; Komada Y; Oda M; Nishimura S; Ishikawa Y; Kudoh T; Ueda K
    Int J Hematol; 2000 Jul; 72(1):61-8. PubMed ID: 10979211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and laboratory biology of childhood acute lymphoblastic leukemia.
    Carroll WL; Raetz EA
    J Pediatr; 2012 Jan; 160(1):10-8. PubMed ID: 21920540
    [No Abstract]   [Full Text] [Related]  

  • 32. Statistical evaluation of prognostic factors in childhood acute lymphoblastic leukemia.
    Derulska D; Rokicka-Milewska R; Lewicki Z
    J Chemother; 1989 Jul; 1(4 Suppl):1273-5. PubMed ID: 16312863
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
    J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in source of information: availability of Varicella vaccine for children with acute lymphocytic leukemia.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jul; 42(25):499. PubMed ID: 8510637
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical relevance of resistance against cytostatic agents in children with leukemia].
    Pieters R; Kaspers GJ; Klumper E; van Wering ER; van der Does-van den Berg A; Veerman AJ
    Ned Tijdschr Geneeskd; 1994 Apr; 138(14):706-12. PubMed ID: 8152511
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Kager L; Lion T; Attarbaschi A; Koenig M; Strehl S; Haas OA; Dworzak MN; Schrappe M; Gadner H; Mann G;
    Haematologica; 2007 Nov; 92(11):1561-4. PubMed ID: 18024406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curing children with leukemia in West Virginia.
    Ritchey AK; Starling KA; Keller FG; Martin J; Steiner ME; Defazio J
    W V Med J; 1997; 93(4):179-81. PubMed ID: 9274141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring residual disease in acute lymphoblastic leukemia: therapeutic implications.
    Roberts WM; Zipf TF; Kitchingman GR; Tubergen DG; Estrov Z
    Cytokines Mol Ther; 1995 Mar; 1(1):65-9. PubMed ID: 9384665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.